BioAdaptives

BioAdaptives Inventory

The Inventory of BioAdaptives (BDPT) as of Oct 26, 2026 is 44,706.00 USD. In the previous year, Inventory was 19,115.00 USD — a change of 133.88% (higher).

Inventory

44,706.00USD

YoY

133.88%

Last updated:

Inventory of BioAdaptives is 2025 44,706.00 USD. Inventory of BioAdaptives was 2024 19,115.00 USD. It decreases by 133.88% higher compared to the previous year.

The BioAdaptives Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
49,857.00 USD
Jan 1, 2019
11,128.00 USD
Jan 1, 2020
13,815.00 USD
Jan 1, 2021
4,750.00 USD
Jan 1, 2022
8,877.00 USD
Jan 1, 2023
15,281.00 USD
Jan 1, 2024
19,115.00 USD
Jan 1, 2025
44,706.00 USD
The BioAdaptives Inventory history
YEARInventoryYoY
44,706.00USD+133.88%
19,115.00USD+25.09%
15,281.00USD+72.14%
8,877.00USD+86.88%
4,750.00USD-65.62%
13,815.00USD+24.15%
11,128.00USD-77.68%
49,857.00USD—
0.00USD-100.00%
135,274.00USD—
0.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BioAdaptives Stock analysis

What does BioAdaptives do? BioAdaptives, Inc. generates revenue through the sale of health and wellness products including dietary supplements, specialty food items, and devices that optimize bioelectromagnetic availability. The company markets PrimiCell and PrimiLive under a product agreement with Ferris Holding, Inc., targeting consumers seeking cognitive enhancement, fatigue reduction, and anti-aging solutions. PrimiTrim serves the weight control segment, while Equine Regen and Equine Regen Plus are in advanced testing for veterinary use. The firm also develops a dog product, expanding its wellness offerings across human and animal health markets. Ferris Holding, Inc. provides the intellectual property and products that BioAdaptives markets, including PrimiCell and PrimiLive, which are positioned for cognition, focus, and emotional wellness. The company's advanced-stage products Equine Regen and Equine Regen Plus cater to the veterinary segment, with PrimiTrim addressing weight management needs. BioAdaptives' product portfolio spans nutraceuticals, devices, and specialty foods designed to improve physical and emotional wellness across multiple consumer segments. BioAdaptives focuses on selling devices and nutraceuticals that target cognitive performance, fatigue reduction, and anti-aging, with PrimiCell and PrimiLive as key products under the Ferris agreement. The company's weight control solution PrimiTrim appeals to consumers seeking wellness through diet, while Equine Regen and Equine Regen Plus target animal health providers. The firm's development of a dog product further diversifies its offerings in the wellness market. BioAdaptives is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioAdaptives stock

Inventory of BioAdaptives is 44,706.00 USD in 2025.

Inventory of BioAdaptives changed from 19,115.00 USD to 44,706.00 USD, representing a 133.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory BioAdaptives since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's BioAdaptives historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — BioAdaptives

All Key Metrics — BioAdaptives